Related Experiment Video
Updated: Jun 1, 2026
11:06
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
A nuclear-receptor-dependent phosphatidylcholine pathway with antidiabetic effects
Jae Man Lee1, Yoon Kwang Lee, Jennifer L Mamrosh
1Program in Developmental Biology, Baylor College of Medicine, Houston, Texas 77030, USA.
Nature
|May 27, 2011
Summary
A novel phosphatidylcholine, dilauroyl phosphatidylcholine (DLPC), acts as an LRH-1 agonist. This discovery reveals a new signaling pathway regulating bile acid metabolism, hepatic triglycerides, and glucose homeostasis.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Molecular Biology
Background:
- Nuclear hormone receptors, including LRH-1 (NR5A2), are key regulators of metabolic pathways.
- Phospholipids have been proposed as ligands for LRH-1, but their functional significance remains undetermined.
Purpose of the Study:
- To investigate the functional role of phospholipids as LRH-1 ligands.
- To identify specific phospholipid species that activate LRH-1 and elucidate their metabolic effects.
Main Methods:
- In vitro assays to identify LRH-1 agonist activity of phosphatidylcholine species.
- In vivo studies using mouse models to assess the effects of DLPC on bile acid biosynthesis, hepatic triglycerides, serum glucose, and insulin resistance.
- Utilizing liver-specific Lrh-1 knockout mice to confirm LRH-1 dependency.
Main Results:
- Dilauroyl phosphatidylcholine (DLPC) was identified as an LRH-1 agonist in vitro.
- DLPC administration in mice increased bile acid levels and induced hepatic enzymes involved in bile acid synthesis.
- DLPC treatment reduced hepatic triglycerides, serum glucose, hepatic steatosis, and improved glucose homeostasis in insulin-resistant mouse models.
- These beneficial effects were abolished in liver-specific Lrh-1 knockout mice.
Conclusions:
- A novel LRH-1 dependent signaling pathway mediated by DLPC regulates bile acid metabolism.
- This pathway plays a critical role in maintaining glucose homeostasis and lipid metabolism.
- DLPC represents a potential therapeutic target for metabolic disorders like insulin resistance and type 2 diabetes.
Related Concept Videos
01:28Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:25cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
01:31Transducer Mechanism: Nuclear Receptors
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
01:27Synthesis of Phosphatidylcholine in the ER Membrane
The ER synthesizes lipids for building cell membranes and performing cellular functions such as energy storage and signaling. The lipid synthesis machinery embedded in the ER membrane primarily collects all reactants from the cytosol. Following synthesis, the secretory pathway and the ER contact sites distribute these lipids to other cellular organelles. Additionally, the energy-rich triacylglycerides are transported from the ER via lipid droplets.
The major components of all eukaryotic cell...
The major components of all eukaryotic cell...